SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-17-006857
Filing Date
2017-04-21
Accepted
2017-04-21 16:05:57
Documents
3
Period of Report
2017-05-24
Effectiveness Date
2017-04-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A cort-def14a_20160519.htm DEF 14A 691391
2 GRAPHIC g201704140550555863624.jpg GRAPHIC 67751
3 GRAPHIC g201704140550556183625.jpg GRAPHIC 57804
  Complete submission text file 0001564590-17-006857.txt   865632
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50679 | Film No.: 17775946
SIC: 2834 Pharmaceutical Preparations